Review



tbev non structural protein 1 ns1 antigen  (Native Antigen Inc)


Bioz Verified Symbol Native Antigen Inc is a verified supplier
Bioz Manufacturer Symbol Native Antigen Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Native Antigen Inc tbev non structural protein 1 ns1 antigen
    Suspension multiplex immunoassay for IgM reactivity with tick-borne encephalitis whole virus vs non-structural <t>protein</t> <t>1</t> antigens in infected (n = 50) vs vaccinated individuals (n = 50) at 0, 120 and 390 days after first vaccination, Sweden, 2017
    Tbev Non Structural Protein 1 Ns1 Antigen, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 94/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tbev+non+structural+protein+1+ns1+antigen/pmc05792698-15-16-23?v=Native+Antigen+Inc
    Average 94 stars, based on 15 article reviews
    tbev non structural protein 1 ns1 antigen - by Bioz Stars, 2026-07
    94/100 stars

    Images

    1) Product Images from "Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017"

    Article Title: Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017

    Journal: Eurosurveillance

    doi: 10.2807/1560-7917.ES.2018.23.3.17-00838

    Suspension multiplex immunoassay for IgM reactivity with tick-borne encephalitis whole virus vs non-structural protein 1 antigens in infected (n = 50) vs vaccinated individuals (n = 50) at 0, 120 and 390 days after first vaccination, Sweden, 2017
    Figure Legend Snippet: Suspension multiplex immunoassay for IgM reactivity with tick-borne encephalitis whole virus vs non-structural protein 1 antigens in infected (n = 50) vs vaccinated individuals (n = 50) at 0, 120 and 390 days after first vaccination, Sweden, 2017

    Techniques Used: Suspension, Multiplex Assay, Virus, Infection

    Tick-borne encephalitis virus reactivity of sera from acutely infected patients (n = 50) vs vaccines (n = 50), at 0, 120 and 390 days after first vaccination, Sweden, 2017
    Figure Legend Snippet: Tick-borne encephalitis virus reactivity of sera from acutely infected patients (n = 50) vs vaccines (n = 50), at 0, 120 and 390 days after first vaccination, Sweden, 2017

    Techniques Used: Virus, Infection, Vaccines

    Suspension multiplex immunoassay for IgG reactivity with tick-borne encephalitis whole virus vs non-structural protein 1 antigens in infected (n = 50) vs vaccinated individuals (n = 50) at 0, 120 and 390 days after first vaccination, Sweden, 2017
    Figure Legend Snippet: Suspension multiplex immunoassay for IgG reactivity with tick-borne encephalitis whole virus vs non-structural protein 1 antigens in infected (n = 50) vs vaccinated individuals (n = 50) at 0, 120 and 390 days after first vaccination, Sweden, 2017

    Techniques Used: Suspension, Multiplex Assay, Virus, Infection



    Similar Products

    tbev non structural protein 1 ns1 antigen  (Native Antigen Inc)
    94
    Native Antigen Inc tbev non structural protein 1 ns1 antigen
    Suspension multiplex immunoassay for IgM reactivity with tick-borne encephalitis whole virus vs non-structural <t>protein</t> <t>1</t> antigens in infected (n = 50) vs vaccinated individuals (n = 50) at 0, 120 and 390 days after first vaccination, Sweden, 2017
    Tbev Non Structural Protein 1 Ns1 Antigen, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tbev+non+structural+protein+1+ns1+antigen/pmc05792698-15-16-23?v=Native+Antigen+Inc
    Average 94 stars, based on 1 article reviews
    tbev non structural protein 1 ns1 antigen - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Suspension multiplex immunoassay for IgM reactivity with tick-borne encephalitis whole virus vs non-structural protein 1 antigens in infected (n = 50) vs vaccinated individuals (n = 50) at 0, 120 and 390 days after first vaccination, Sweden, 2017

    Journal: Eurosurveillance

    Article Title: Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017

    doi: 10.2807/1560-7917.ES.2018.23.3.17-00838

    Figure Lengend Snippet: Suspension multiplex immunoassay for IgM reactivity with tick-borne encephalitis whole virus vs non-structural protein 1 antigens in infected (n = 50) vs vaccinated individuals (n = 50) at 0, 120 and 390 days after first vaccination, Sweden, 2017

    Article Snippet: TBEV whole virus (WV) antigen was purchased from Jena Bioscience, Jena, Germany (Cat. No. PR-BA112) and TBEV non-structural protein 1 (NS1) antigen from Native Antigen Company, Heyford Park, United Kingdom (Cat. No. TBEV-NS1–100).

    Techniques: Suspension, Multiplex Assay, Virus, Infection

    Tick-borne encephalitis virus reactivity of sera from acutely infected patients (n = 50) vs vaccines (n = 50), at 0, 120 and 390 days after first vaccination, Sweden, 2017

    Journal: Eurosurveillance

    Article Title: Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017

    doi: 10.2807/1560-7917.ES.2018.23.3.17-00838

    Figure Lengend Snippet: Tick-borne encephalitis virus reactivity of sera from acutely infected patients (n = 50) vs vaccines (n = 50), at 0, 120 and 390 days after first vaccination, Sweden, 2017

    Article Snippet: TBEV whole virus (WV) antigen was purchased from Jena Bioscience, Jena, Germany (Cat. No. PR-BA112) and TBEV non-structural protein 1 (NS1) antigen from Native Antigen Company, Heyford Park, United Kingdom (Cat. No. TBEV-NS1–100).

    Techniques: Virus, Infection, Vaccines

    Suspension multiplex immunoassay for IgG reactivity with tick-borne encephalitis whole virus vs non-structural protein 1 antigens in infected (n = 50) vs vaccinated individuals (n = 50) at 0, 120 and 390 days after first vaccination, Sweden, 2017

    Journal: Eurosurveillance

    Article Title: Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017

    doi: 10.2807/1560-7917.ES.2018.23.3.17-00838

    Figure Lengend Snippet: Suspension multiplex immunoassay for IgG reactivity with tick-borne encephalitis whole virus vs non-structural protein 1 antigens in infected (n = 50) vs vaccinated individuals (n = 50) at 0, 120 and 390 days after first vaccination, Sweden, 2017

    Article Snippet: TBEV whole virus (WV) antigen was purchased from Jena Bioscience, Jena, Germany (Cat. No. PR-BA112) and TBEV non-structural protein 1 (NS1) antigen from Native Antigen Company, Heyford Park, United Kingdom (Cat. No. TBEV-NS1–100).

    Techniques: Suspension, Multiplex Assay, Virus, Infection